Recent Advances in Our Understanding of Human Inflammatory Dendritic Cells in Human Immunodeficiency Virus Infection

Anogenital inflammation is a critical risk factor for HIV acquisition. The primary preventative HIV intervention, pre-exposure prophylaxis (PrEP), is ineffective in blocking transmission in anogenital inflammation. Pre-existing sexually transmitted diseases (STIs) and anogenital microbiota dysbiosis...

Full description

Saved in:
Bibliographic Details
Main Authors: Freja A. Warner van Dijk, Kirstie M. Bertram, Thomas R. O’Neil, Yuchen Li, Daniel J. Buffa, Andrew N. Harman, Anthony L. Cunningham, Najla Nasr
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/17/1/105
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832587321500762112
author Freja A. Warner van Dijk
Kirstie M. Bertram
Thomas R. O’Neil
Yuchen Li
Daniel J. Buffa
Andrew N. Harman
Anthony L. Cunningham
Najla Nasr
author_facet Freja A. Warner van Dijk
Kirstie M. Bertram
Thomas R. O’Neil
Yuchen Li
Daniel J. Buffa
Andrew N. Harman
Anthony L. Cunningham
Najla Nasr
author_sort Freja A. Warner van Dijk
collection DOAJ
description Anogenital inflammation is a critical risk factor for HIV acquisition. The primary preventative HIV intervention, pre-exposure prophylaxis (PrEP), is ineffective in blocking transmission in anogenital inflammation. Pre-existing sexually transmitted diseases (STIs) and anogenital microbiota dysbiosis are the leading causes of inflammation, where inflammation is extensive and often asymptomatic and undiagnosed. Dendritic cells (DCs), as potent antigen-presenting cells, are among the first to capture HIV upon its entry into the mucosa, and they subsequently transport the virus to CD4 T cells, the primary HIV target cells. This increased HIV susceptibility in inflamed tissue likely stems from a disrupted epithelial barrier integrity, phenotypic changes in resident DCs and an influx of inflammatory HIV target cells, including DCs and CD4 T cells. Gaining insight into how HIV interacts with specific inflammatory DC subsets could inform the development of new therapeutic strategies to block HIV transmission. However, little is known about the early stages of HIV capture and transmission in inflammatory environments. Here, we review the currently characterised inflammatory-tissue DCs and their interactions with HIV.
format Article
id doaj-art-df2885473eaf4259b8ef22e2855f71ce
institution Kabale University
issn 1999-4915
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj-art-df2885473eaf4259b8ef22e2855f71ce2025-01-24T13:52:36ZengMDPI AGViruses1999-49152025-01-0117110510.3390/v17010105Recent Advances in Our Understanding of Human Inflammatory Dendritic Cells in Human Immunodeficiency Virus InfectionFreja A. Warner van Dijk0Kirstie M. Bertram1Thomas R. O’Neil2Yuchen Li3Daniel J. Buffa4Andrew N. Harman5Anthony L. Cunningham6Najla Nasr7Centre for Virus Research, The Westmead Institute for Medical Research, Westmead 2145, AustraliaCentre for Virus Research, The Westmead Institute for Medical Research, Westmead 2145, AustraliaCentre for Virus Research, The Westmead Institute for Medical Research, Westmead 2145, AustraliaCentre for Virus Research, The Westmead Institute for Medical Research, Westmead 2145, AustraliaCentre for Virus Research, The Westmead Institute for Medical Research, Westmead 2145, AustraliaCentre for Virus Research, The Westmead Institute for Medical Research, Westmead 2145, AustraliaCentre for Virus Research, The Westmead Institute for Medical Research, Westmead 2145, AustraliaCentre for Virus Research, The Westmead Institute for Medical Research, Westmead 2145, AustraliaAnogenital inflammation is a critical risk factor for HIV acquisition. The primary preventative HIV intervention, pre-exposure prophylaxis (PrEP), is ineffective in blocking transmission in anogenital inflammation. Pre-existing sexually transmitted diseases (STIs) and anogenital microbiota dysbiosis are the leading causes of inflammation, where inflammation is extensive and often asymptomatic and undiagnosed. Dendritic cells (DCs), as potent antigen-presenting cells, are among the first to capture HIV upon its entry into the mucosa, and they subsequently transport the virus to CD4 T cells, the primary HIV target cells. This increased HIV susceptibility in inflamed tissue likely stems from a disrupted epithelial barrier integrity, phenotypic changes in resident DCs and an influx of inflammatory HIV target cells, including DCs and CD4 T cells. Gaining insight into how HIV interacts with specific inflammatory DC subsets could inform the development of new therapeutic strategies to block HIV transmission. However, little is known about the early stages of HIV capture and transmission in inflammatory environments. Here, we review the currently characterised inflammatory-tissue DCs and their interactions with HIV.https://www.mdpi.com/1999-4915/17/1/105plasmacytoid DC (pDC)Axl<sup>+</sup> Siglec-6<sup>+</sup> DC (ASDC)DC3monocyte-derived dendritic cellsepidermal CD11c<sup>+</sup> dendritic cellsinflammation
spellingShingle Freja A. Warner van Dijk
Kirstie M. Bertram
Thomas R. O’Neil
Yuchen Li
Daniel J. Buffa
Andrew N. Harman
Anthony L. Cunningham
Najla Nasr
Recent Advances in Our Understanding of Human Inflammatory Dendritic Cells in Human Immunodeficiency Virus Infection
Viruses
plasmacytoid DC (pDC)
Axl<sup>+</sup> Siglec-6<sup>+</sup> DC (ASDC)
DC3
monocyte-derived dendritic cells
epidermal CD11c<sup>+</sup> dendritic cells
inflammation
title Recent Advances in Our Understanding of Human Inflammatory Dendritic Cells in Human Immunodeficiency Virus Infection
title_full Recent Advances in Our Understanding of Human Inflammatory Dendritic Cells in Human Immunodeficiency Virus Infection
title_fullStr Recent Advances in Our Understanding of Human Inflammatory Dendritic Cells in Human Immunodeficiency Virus Infection
title_full_unstemmed Recent Advances in Our Understanding of Human Inflammatory Dendritic Cells in Human Immunodeficiency Virus Infection
title_short Recent Advances in Our Understanding of Human Inflammatory Dendritic Cells in Human Immunodeficiency Virus Infection
title_sort recent advances in our understanding of human inflammatory dendritic cells in human immunodeficiency virus infection
topic plasmacytoid DC (pDC)
Axl<sup>+</sup> Siglec-6<sup>+</sup> DC (ASDC)
DC3
monocyte-derived dendritic cells
epidermal CD11c<sup>+</sup> dendritic cells
inflammation
url https://www.mdpi.com/1999-4915/17/1/105
work_keys_str_mv AT frejaawarnervandijk recentadvancesinourunderstandingofhumaninflammatorydendriticcellsinhumanimmunodeficiencyvirusinfection
AT kirstiembertram recentadvancesinourunderstandingofhumaninflammatorydendriticcellsinhumanimmunodeficiencyvirusinfection
AT thomasroneil recentadvancesinourunderstandingofhumaninflammatorydendriticcellsinhumanimmunodeficiencyvirusinfection
AT yuchenli recentadvancesinourunderstandingofhumaninflammatorydendriticcellsinhumanimmunodeficiencyvirusinfection
AT danieljbuffa recentadvancesinourunderstandingofhumaninflammatorydendriticcellsinhumanimmunodeficiencyvirusinfection
AT andrewnharman recentadvancesinourunderstandingofhumaninflammatorydendriticcellsinhumanimmunodeficiencyvirusinfection
AT anthonylcunningham recentadvancesinourunderstandingofhumaninflammatorydendriticcellsinhumanimmunodeficiencyvirusinfection
AT najlanasr recentadvancesinourunderstandingofhumaninflammatorydendriticcellsinhumanimmunodeficiencyvirusinfection